Patient Derived Equipment In Europe
-
Manufactured by Cellesce Ltdbased in UNITED KINGDOM
Derived from patient tissue our colorectal cancer organoids are available from a range of sites and TNM stages. They cover varied morphologies and growth ...
-
Manufactured by Cellesce Ltdbased in UNITED KINGDOM
Organoids are derived from biopsies and tissues sampled from patients or subjects (usually termed Patient-Derived Organoids, or PDOs). PDOs are self-organising cell structures that mimic the tissue or organ from which they are derived – they are often termed ‘mini-organs’. ...
-
Manufactured by InSphero AGbased in SWITZERLAND
An in vitro PDX model with in vivo-like heterogeneity. 3D InSight™ Tumor Microtissues from Patient-Derived Xenografts (PDX) are custom assay-ready 3D in vitro tumor models engineered to reflect complex tumor biology without the use of artificial matrices. Ideal for early stage cancer drug efficacy testing and screening ...
-
Manufactured by CNSystems Medizintechnik GmbHbased in AUSTRIA
Task Force Touch CARDIO provides a set of synchronized patient signals derived from the unique non-invasive CNAP finger sensor, combined with wireless 12-channel ECG. It is patient-friendly, easy to use and supports you in your busy daily clinical routine when it matters ...
-
Manufactured by RTsafebased in GREECE
Encephalon 3D is a single-use head phantom constructed from bone equivalent material. The brain is filled with 3D polymer gel dosimeter, as a tissue equivalent material, giving to the end-user the ability to gain a real-3D map of the delivered ...
-
Manufactured by Exscientiabased in UNITED KINGDOM
EXS21546 is our peripherally-restricted and selective antagonist of the Adenosine A2a Receptor. It is designed for anti-cancer immunotherapy, combatting adenosine related immunosuppressive effects, through T-cell ...
-
Manufactured by Benevolentbased in UNITED KINGDOM
work on all patients. Our work focuses on developing safer and more effective oral small molecule treatments. Progress so far: For our most advanced UC programme, we identified an AI-generated target with novel mechanisms of action in UC, and rapidly delivered a candidate drug to IND/CTA-enabling ...
-
Manufactured by Alzinova ABbased in SWEDEN
ALZ-101 is a vaccine that stimulates the production of antibodies against the toxic Aβ oligomers. A first-in-human study in patients with early Alzheimer’s disease was initiated during third quarter of ...
-
by Oncodesignbased in FRANCE
This is the best tool you can use to evaluate new therapeutic approaches in conditions that are as close as possible to a clinical situation: ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you